Nitric Oxide Therapy System Market Size, Share, Growth, and Industry Analysis, By Type (Portable System and Fixed System), By Application (Hospitals, Homecare Settings, and Others), Regional Insights and Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

NITRIC OXIDE THERAPY SYSTEM MARKET OVERVIEW

The global nitric oxide therapy system market size was USD 0.04 billion in 2024 and market is projected to touch USD 0.06 billion by 2033, exhibiting a CAGR of 5.4% during the forecast period from 2025 To 2033.

Nitric oxide therapy is a successful treatment method for PPH, ARDS, and PPHN. The therapy helps to vasodilate the blood vessels in the ventilated part of the lung and reduce artery pressure.

Increased prevalence of hypoxic respiratory failures and pulmonary hypertension is predicted to expand market growth. High awareness about refined healthcare infrastructure is projected to propel market progress. A rise in the prevalence of chronic diseases is estimated to surge market growth. The growing geriatric population and the high demand to adopt medical devices are anticipated to foster market growth. Increased number of pulmonary hypertension in newborns (PPHN) is expected to expand market growth. Ongoing research and development (R&D) activities coupled with new development in the healthcare sector are estimated to propel market growth. On the contrary, the high cost of the treatment and government regulations for several application is predicted to hamper the market growth in the upcoming years.

COVID-19 IMPACT

Increase Number Coronavirus Cases to Fuel Market Progress during Pandemic

COVID-19 patients suffered from respiratory failure. High demand to treat coronavirus to fuel market growth. Huge demand for the treatment during the pandemic to augment market growth. Further, growth in the healthcare sector and the huge adoption of advanced healthcare treatment fuel market growth.

LATEST TRENDS

Rise of Respiratory Diseases to Foster Market Growth

An increase in the number of respiratory diseases at the global level is predicted to fuel market growth. High demand to treat respiratory disorders is estimated to bolster market progress. Increased prevalence of hypoxic respiratory failures and pulmonary hypertension is predicted to expand market growth. The therapy works by soothing or relaxing the smooth muscles to enlarge the blood vessels in the lungs. These factors are expected to propel market growth. High demand to relax muscle tension and dilate blood vessels is anticipated to accelerate market growth. Further, the high adoption of advanced technology in the healthcare sector is predicted to fuel market growth. Increased disposable income and a high spending capacity of the population are projected to expand nitric oxide therapy system market growth in the upcoming years.

Request a Free sample to learn more about this report

NITRIC OXIDE THERAPY SYSTEM MARKET SEGMENTATION

By Type

Based on type, the market is divided into the portable system and fixed system.

Portable system is estimated to be the leading part of type segmentation.

By Application

Based on application, the market is classified into hospitals, homecare settings, and others.

Hospitals are estimated to be the leading part of application segmentation.

DRIVING FACTORS

Increase in the Prevalence of Diseases Among Newborn to Bolster Market Growth

Growing prevalence of diseases among newborns such as neonatal hypoxic respiratory failure (HRF) and persistent pulmonary. These diseases need to be treated and high demand for the treatment is predicted to augment market growth. Further, an increase in the number of patients with acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary diseases (COPD) is estimated to expand market growth. High adoption of the treatment in the healthcare sector is anticipated to fuel market growth in the upcoming years. The treatment is very safe and rapid offset which is estimated to boost the therapy adoption. In addition, the treatment offers rapid results and requires less time. Such advantages of the product are projected to drive nitric oxide therapy system market growth.

Rise in the Prevalence of Chronic Diseases to Foster Market Growth

A rise in the prevalence of chronic diseases is estimated to surge market growth. The growing geriatric population and the high demand to adopt medical devices are anticipated to foster market growth. Increased number of pulmonary hypertension in newborns (PPHN) is expected to expand market growth. Ongoing research and development (R&D) activities coupled with new development in the healthcare sector are estimated to propel market growth. Government initiatives to develop new and effective treatment is projected to surge market progress. Increased outbreaks of respiratory diseases such as COVID-19 and SARC are anticipated to expand nitric oxide therapy system market growth over the forecast period.

RESTRAINING FACTORS

Higher Cost and Government Regulations to Obstruct Market Progress

The high cost of the treatment and government regulations for several application is predicted to hamper the market growth in the upcoming years.

• Request a Free sample to learn more about this report

•  

NITRIC OXIDE THERAPY SYSTEM MARKET REGIONAL INSIGHTS

Increase in Awareness About Respiratory Disorders and Illness in North America to Drive Market Share

North America is estimated to hold the leading position in nitric oxide therapy system market share owing to an increase in awareness about respiratory disorders and illness. Growing demand for refined healthcare infrastructure is projected to drive market growth. A rise in the geriatric population is estimated to drive market growth. The growing prevalence of diseases among newborns such as neonatal hypoxic respiratory failure (HRF) and persistent pulmonary in the region is anticipated to accelerate nitric oxide therapy system market growth.

Europe is projected to drive market growth owing to high awareness about refined healthcare infrastructure is projected to propel market progress. A rise in the prevalence of chronic diseases is estimated to surge market growth. The growing geriatric population and the high demand to adopt medical devices are anticipated to foster market growth. Increased number of pulmonary hypertension in newborns (PPHN) is expected to expand market growth. Ongoing research and development (R&D) activities coupled with new development in the healthcare sector are estimated to propel nitric oxide therapy system market growth.

KEY INDUSTRY PLAYERS

Leading Players Adopt Strategies to Stay Competitive

The report covers information about the list of market players and their latest development in the Industry. The information includes mergers, partnerships, acquisitions, technological developments, and production lines. Other aspects examined for this market include complete research on companies producing and introducing the latest products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.

List of Top Nitric Oxide Therapy System Companies

• Bellerophon Therapeutics (U.S.)
• BOC Healthcare (Australia)
• Dan Hammer Health (U.S.)
• EKU Elektronik GmbH (Germany)
• GeNO LLC (U.S.)
• International Biomedical (U.S.)
• SLE (U.S.)
• Mallinckrodt Pharmaceuticals (U.K.)
• Praxair (U.S.)
• Vapotherm (U.S.)
• Linde Group (Ireland)

REPORT COVERAGE

This research profiles a report with general studies that explain the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by examining the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, and others. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.